Add-on therapy: When two are not better than one
暂无分享,去创建一个
[1] G. Cruccu,et al. Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain , 2013, PAIN®.
[2] P. Wiffen,et al. COMBINATION PHARMACOTHERAPY FOR THE TREATMENT OF NEUROPATHIC PAIN IN ADULTS , 2012, The Cochrane database of systematic reviews.
[3] J. Berlin,et al. Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. , 2012, Pain medicine.
[4] A. J. Green,et al. Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses. , 2010, Diabetes research and clinical practice.
[5] D. Tu,et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial , 2009, The Lancet.
[6] M. Versavel,et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double‐blind study , 2008, European journal of pain.
[7] J. Farrar,et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations , 2007, PAIN.
[8] M. Max,et al. Combination pharmacotherapy for neuropathic pain: current evidence and future directions , 2005, Expert review of neurotherapeutics.
[9] R. Dworkin,et al. NEUROPATHIC PAIN SECTION Original Research Articles Experience and Challenges Presented by a Multicenter Crossover Study of Combination Analgesic Therapy for the Treatment of Painful HIV-Associated Polyneuropathies , 2016 .
[10] BMC Neurology BioMed Central , 2008 .